Über uns

up to data, founded in 1992, is an international provider of innovative and customizable IT solutions for the Life Sciences, pharmaceutical, chemical, and biotech industries with offices in Europe, North America, and Asia-Pacific.

The company's product offerings include lab data management and data review applications, as well as report writing solutions. up to data with its innovative data management platform, StudyGen 360 is a highly specialized provider of study data management and GXP-compliant study reporting solutions that satisfy pharmaceutical regulatory requirements.

up to data's solutions are designed to meet the latest industry regulations, including GMP, ISO 17025, and FDA 21 CFR Part 11. The company's quality management system is certified by DQS following the standard for DIN EN ISO 9001:2015. Through long-term partnerships with industry leaders, up to data ensures that its solutions support the latest technologies while meeting individual customer requirements.

Whether working on early-stage drug development, vaccine research, or stability studies, up to data delivers solutions that integrate seamlessly into existing working environments and support individual processes, helping to improve time-to-market significantly through automated workflows.

For more information about up to data, please visit our website or follow us on LinkedIn.

PRESS CONTACT:

up to data GmbH

Energie-Allee 1, 55286 Wörrstadt, Germany

Phone: + 49 6732 9490-0

Email: info[at]uptodata.com

Website: www.uptodata.com